- Report
- June 2023
- 107 Pages
Global
From €3500EUR$3,878USD£3,091GBP
- Report
- June 2023
- 93 Pages
Global
From €3500EUR$3,878USD£3,091GBP
- Report
- February 2023
- 220 Pages
Global
From €5540EUR$5,730USD£4,727GBP
- Report
- January 2023
- 220 Pages
Global
From €5540EUR$5,730USD£4,727GBP
- Report
- January 2023
- 220 Pages
Global
From €5540EUR$5,730USD£4,727GBP
- Report
- December 2021
- 280 Pages
Global
From €5964EUR$6,168USD£5,088GBP
The Cerebrospinal Fluid Management market within the context of Neurology Devices is a specialized segment of the medical device industry. It includes a range of products used to manage cerebrospinal fluid (CSF) in the treatment of neurological disorders. These products include CSF shunts, CSF drainage systems, CSF collection systems, CSF filtration systems, and CSF monitoring systems. These devices are used to treat hydrocephalus, a condition in which CSF accumulates in the brain, and other neurological disorders.
The Cerebrospinal Fluid Management market is highly competitive, with a number of companies offering a range of products. These companies include Medtronic, Integra LifeSciences, B. Braun, Codman & Shurtleff, and Natus Medical. Other companies in the market include Stryker, DePuy Synthes, and Smiths Medical. Show Less Read more